INTERCOS SPA (ICOS.MI) Stock Fundamental Analysis
BIT:ICOS - Euronext Milan - IT0005455875 - Common Stock - Currency: EUR
ICOS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 12 industry peers in the Personal Care Products industry. ICOS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, ICOS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
ICOS had positive earnings in the past year.
ICOS had a positive operating cash flow in the past year.
In the past 5 years ICOS has always been profitable.
ICOS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ICOS has a worse Return On Assets (4.47%) than 66.67% of its industry peers.
ICOS has a worse Return On Equity (10.11%) than 66.67% of its industry peers.
ICOS has a Return On Invested Capital (11.79%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for ICOS is below the industry average of 12.78%.
The 3 year average ROIC (9.12%) for ICOS is below the current ROIC(11.79%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.47% | ||
| ROE | 10.11% | ||
| ROIC | 11.79% |
ROA(3y)4.28%
ROA(5y)4.65%
ROE(3y)10.02%
ROE(5y)12.49%
ROIC(3y)9.12%
ROIC(5y)9.57%
1.3 Margins
ICOS's Profit Margin of 4.51% is in line compared to the rest of the industry. ICOS outperforms 41.67% of its industry peers.
ICOS's Profit Margin has declined in the last couple of years.
The Operating Margin of ICOS (8.72%) is worse than 66.67% of its industry peers.
ICOS's Operating Margin has declined in the last couple of years.
ICOS has a Gross Margin of 19.61%. This is amonst the worse of the industry: ICOS underperforms 91.67% of its industry peers.
ICOS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.72% | ||
| PM (TTM) | 4.51% | ||
| GM | 19.61% |
OM growth 3Y5.36%
OM growth 5Y-2.46%
PM growth 3Y-5.79%
PM growth 5Y-5%
GM growth 3Y-0.48%
GM growth 5Y-2.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ICOS is creating some value.
The number of shares outstanding for ICOS remains at a similar level compared to 1 year ago.
ICOS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ICOS has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.22 indicates that ICOS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.22, ICOS is in line with its industry, outperforming 50.00% of the companies in the same industry.
The Debt to FCF ratio of ICOS is 1.25, which is an excellent value as it means it would take ICOS, only 1.25 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.25, ICOS belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that ICOS is not too dependend on debt financing.
ICOS has a better Debt to Equity ratio (0.10) than 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 1.25 | ||
| Altman-Z | 3.22 |
ROIC/WACC1.5
WACC7.86%
2.3 Liquidity
ICOS has a Current Ratio of 1.10. This is a normal value and indicates that ICOS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.10, ICOS is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Quick Ratio of 0.66 indicates that ICOS may have some problems paying its short term obligations.
ICOS has a Quick ratio (0.66) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
ICOS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.54%.
ICOS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.17% yearly.
ICOS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.57%.
The Revenue has been growing slightly by 7.40% on average over the past years.
EPS 1Y (TTM)-12.54%
EPS 3Y9.52%
EPS 5Y1.17%
EPS Q2Q%-28.96%
Revenue 1Y (TTM)4.57%
Revenue growth 3Y17.67%
Revenue growth 5Y7.4%
Sales Q2Q%2.36%
3.2 Future
ICOS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.47% yearly.
ICOS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.50% yearly.
EPS Next Y4.64%
EPS Next 2Y9.52%
EPS Next 3Y11.16%
EPS Next 5Y10.47%
Revenue Next Year7.26%
Revenue Next 2Y6.87%
Revenue Next 3Y6.73%
Revenue Next 5Y2.5%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 29.66, the valuation of ICOS can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ICOS indicates a rather expensive valuation: ICOS more expensive than 83.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.82, ICOS is valued at the same level.
With a Price/Forward Earnings ratio of 19.20, ICOS is valued on the expensive side.
ICOS's Price/Forward Earnings is on the same level as the industry average.
ICOS's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.76.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.66 | ||
| Fwd PE | 19.2 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICOS indicates a somewhat cheap valuation: ICOS is cheaper than 66.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ICOS is valued more expensive than 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.35 | ||
| EV/EBITDA | 9.41 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)6.39
PEG (5Y)25.45
EPS Next 2Y9.52%
EPS Next 3Y11.16%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.45%, ICOS has a reasonable but not impressive dividend return.
ICOS's Dividend Yield is slightly below the industry average, which is at 2.55.
Compared to the average S&P500 Dividend Yield of 2.39, ICOS is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.45% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
42.88% of the earnings are spent on dividend by ICOS. This is a bit on the high side, but may be sustainable.
DP42.88%
EPS Next 2Y9.52%
EPS Next 3Y11.16%
BIT:ICOS (5/23/2025, 7:00:00 PM)
13.94
+0.48 (+3.57%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners39.17%
Inst Owner ChangeN/A
Ins Owners32.2%
Ins Owner ChangeN/A
Market Cap1.34B
Analysts85.71
Price Target17.59 (26.18%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.45% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP42.88%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.06%
PT rev (3m)-3.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.66 | ||
| Fwd PE | 19.2 | ||
| P/S | 1.34 | ||
| P/FCF | 31.35 | ||
| P/OCF | 14.11 | ||
| P/B | 3.01 | ||
| P/tB | 5.26 | ||
| EV/EBITDA | 9.41 |
EPS(TTM)0.47
EY3.37%
EPS(NY)0.73
Fwd EY5.21%
FCF(TTM)0.44
FCFY3.19%
OCF(TTM)0.99
OCFY7.09%
SpS10.38
BVpS4.63
TBVpS2.65
PEG (NY)6.39
PEG (5Y)25.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.47% | ||
| ROE | 10.11% | ||
| ROCE | 16.85% | ||
| ROIC | 11.79% | ||
| ROICexc | 15.93% | ||
| ROICexgc | 31.75% | ||
| OM | 8.72% | ||
| PM (TTM) | 4.51% | ||
| GM | 19.61% | ||
| FCFM | 4.29% |
ROA(3y)4.28%
ROA(5y)4.65%
ROE(3y)10.02%
ROE(5y)12.49%
ROIC(3y)9.12%
ROIC(5y)9.57%
ROICexc(3y)13.17%
ROICexc(5y)13.68%
ROICexgc(3y)24.59%
ROICexgc(5y)25.8%
ROCE(3y)13.03%
ROCE(5y)13.69%
ROICexcg growth 3Y24.46%
ROICexcg growth 5Y11.44%
ROICexc growth 3Y21.76%
ROICexc growth 5Y5.26%
OM growth 3Y5.36%
OM growth 5Y-2.46%
PM growth 3Y-5.79%
PM growth 5Y-5%
GM growth 3Y-0.48%
GM growth 5Y-2.03%
F-Score5
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 1.25 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 112.13% | ||
| Cap/Sales | 5.23% | ||
| Interest Coverage | 18.71 | ||
| Cash Conversion | 71.1% | ||
| Profit Quality | 94.94% | ||
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z | 3.22 |
F-Score5
WACC7.86%
ROIC/WACC1.5
Cap/Depr(3y)108.68%
Cap/Depr(5y)109.85%
Cap/Sales(3y)5.59%
Cap/Sales(5y)5.96%
Profit Quality(3y)82.87%
Profit Quality(5y)94.39%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.54%
EPS 3Y9.52%
EPS 5Y1.17%
EPS Q2Q%-28.96%
EPS Next Y4.64%
EPS Next 2Y9.52%
EPS Next 3Y11.16%
EPS Next 5Y10.47%
Revenue 1Y (TTM)4.57%
Revenue growth 3Y17.67%
Revenue growth 5Y7.4%
Sales Q2Q%2.36%
Revenue Next Year7.26%
Revenue Next 2Y6.87%
Revenue Next 3Y6.73%
Revenue Next 5Y2.5%
EBIT growth 1Y-7.51%
EBIT growth 3Y23.97%
EBIT growth 5Y4.76%
EBIT Next Year58.29%
EBIT Next 3Y24.15%
EBIT Next 5Y20.08%
FCF growth 1Y4150.5%
FCF growth 3Y-1.18%
FCF growth 5Y1.22%
OCF growth 1Y134.98%
OCF growth 3Y4.1%
OCF growth 5Y4.57%